(Q48712273)

English

A double-blind, placebo-controlled dose-response study with budesonide Turbuhaler in Japanese asthma patients. Japanese Pulmicort Turbuhaler study group.

scientific article published in September 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

A double-blind, placebo-controlled dose-response study with budesonide Turbuhaler in Japanese asthma patients. Japanese Pulmicort Turbuhaler study group. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

0 references

1 reference

based on heuristic

inferred from title

author name string

Miyamoto T

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Takahashi T

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Nakajima S

3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Makino S

4

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Yamakido M

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Mano K

6

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Nakashima M

7

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Tollemar U

8

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Selroos O

9

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

publication date

1 September 2000

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

247-256

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Inhaled glucocorticoids for asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Dose-proportional pharmacokinetics of budesonide inhaled via Turbuhaler

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Clinical pharmacology of corticosteroids in bronchial asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Response of patients receiving high dose beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Acute dose-response studies in bronchial asthma with a new corticosteroid, budesonide

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Local versus total systemic bioavailability as a means to compare different inhaled formulations of the same substance.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2000.00256.X

21 January 2018

Identifiers

10.1046/J.1440-1843.2000.00256.X

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

release_6weypniw3rgwtjcxtg2mee6yue

1 reference

https://api.fatcat.wiki/v0/release/6weypniw3rgwtjcxtg2mee6yue

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11022987

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48712273&oldid=1835782707"